netFormulary
 Report : A-Z HCD items in Formulary 25/07/2021 09:20:09
[Back]
 
Section Status CCG Name
01.05.03 Formulary CCG Adalimumab Amgevita
10.01.03 Formulary CCG Adalimumab Amgevita
13.05.03 Formulary CCG Adalimumab Amgevita
13.05.03 Formulary CCG Adalimumab Amgevita
13.05.03 Formulary CCG Brodalumab Kyntheum
13.05.03 Formulary CCG Certolizumab  Cimzia
13.05.03 Formulary CCG Dimethyl fumarate Skilarence
13.05.03 Formulary CCG Dupilumab Dupixent
04.07.04.02 Restricted Use CCG Erenumab 
13.05.03 Formulary CCG Etanercept Benepali
04.07.04.02 Formulary CCG Fremanezumab Ajovy
04.07.04.02 Formulary CCG Galcanezumab Emgality
01.05.03 Formulary CCG Golimumab Simponi
13.05.03 Formulary CCG Golimumab Simponi
13.05.03 Formulary CCG Guselkumab Tremfya
01.05.03 Formulary CCG Infliximab Remsima
13.05.03 Formulary CCG Infliximab Remsima
13.05.03 Formulary CCG Ixekizumab Taltz
13.05.03 Formulary CCG Omalizumab Xolair
13.05.03 Formulary CCG Risankizumab Skyrizi
13.05.03 Formulary CCG Secukinumab Cosentyx
13.05.03 Formulary CCG Tildrakizumab Ilumetri
01.05.03 Formulary CCG Tofacitinib Xeljanz
13.05.03 Formulary CCG Tofacitinib Xeljanz
10.01.03 Formulary CCG Upadacitinib  Rinvoq
01.05.03 Formulary CCG Ustekinumab Stelara
13.05.03 Restricted Use CCG Ustekinumab Stelara
01.05.03 Formulary CCG Vedolizumab Entyvio
Bradford Teaching Hospitals